SalioGen Therapeutics

SalioGen Therapeutics was a next-generation genetic medicine company, formerly based in Lexington, Massachusetts, developing gene therapies. It was surfaced as a portfolio company of d1-capital and added to the API Evangelist network as a biotech stub. As of the 2026-07-21 enrichment pass its website (saliogen.com) serves only a minimal holding page indicating the company is no longer operating; no developer portal, API, documentation, blog, or other public technical surface was found.

SalioGen Therapeutics is profiled on the APIs.io network. Tagged areas include Company, Biotech, Genetic Medicine, Gene Therapy, and Life Sciences.

🌐 Visit website 📡 Source on GitHub
7.7/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-07-27 · rubric v0.5
0 APIs
CompanyBiotechGenetic MedicineGene TherapyLife SciencesDefunct

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-07-27 · rubric v0.5
Composite quality — 7.7/100 · minimal
Contract Quality 0.0 / 25
Developer Ergonomics 0.0 / 20
Commercial Clarity 0.0 / 20
Operational Transparency 0.0 / 13
Governance 0.0 / 12
Discoverability 6.8 / 10
Agent readiness — 0/100 · human only
Machine-Readable Contract 0 / 18
Agentic Access Contract 0 / 15
MCP Server 0 / 12
Machine-Readable Auth 0 / 10
Idempotency 0 / 9
Stable Error Semantics 0 / 8
Request/Response Examples 0 / 7
Rate-Limit Signaling 0 / 7
Typed Event Surface 0 / 6
Agent Skills 0 / 5
Well-Known Catalog 0 / 4
Consent & Bot Identity 0 / 3
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/saliogen-therapeutics: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Security Posture 1

Authentication, domain security, vulnerability disclosure, and trust-center signals.

Saliogen Therapeutics Domain Security

TLSv1.3

SECURITY

Resources

Access & Security 1

Authentication, authorization, and security posture

DomainSecurity
DomainSecurity

Company 1

The organization behind the API

Website
Website

Source (apis.yml)

apis.yml Raw ↑ 
aid: saliogen-therapeutics
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/saliogen-therapeutics.png
name: SalioGen Therapeutics
description: SalioGen Therapeutics was a next-generation genetic medicine company, formerly based in Lexington, Massachusetts,
  developing gene therapies. It was surfaced as a portfolio company of d1-capital and added to the API Evangelist network
  as a biotech stub. As of the 2026-07-21 enrichment pass its website (saliogen.com) serves only a minimal holding page indicating
  the company is no longer operating; no developer portal, API, documentation, blog, or other public technical surface was
  found.
url: https://raw.githubusercontent.com/api-evangelist/saliogen-therapeutics/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- d1-capital
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-21'
tags:
- Company
- Biotech
- Genetic Medicine
- Gene Therapy
- Life Sciences
- Defunct
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/saliogen-therapeutics-domain-security.yml
- type: Website
  url: https://saliogen.com
x-enrichment:
  date: '2026-07-21'
  status: minimal
  artifacts_added: 1
  pass: local-v1